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Abstract. 
 
Rab escort proteins (REP) 1 and 2 are 
closely related mammalian proteins required for pren-
ylation of newly synthesized Rab GTPases by the cyto-
solic heterodimeric Rab geranylgeranyl transferase II 
complex (RabGG transferase). REP1 in mammalian 
cells is the product of the choroideremia gene (CHM). 
CHM/REP1 deﬁciency in inherited disease leads to de-
generation of retinal pigmented epithelium and loss of 
vision. We now show that amino acid residues required 
for Rab recognition are critical for function of the yeast 
REP homologue Mrs6p, an essential protein that shows 
50% homology to mammalian REPs. Mutant Mrs6p 
unable to bind Rabs failed to complement growth of a 
 
mrs6
 
D
 
 
 
null strain and were found to be dominant inhib-
itors of growth in a wild-type 
 
MRS6 
 
strain. Mutants 
were identiﬁed that did not affect Rab binding, yet pre-
vented prenylation in vitro and failed to support growth 
of the 
 
mrs6
 
D
 
 
 
null strain. These results suggest that in 
the absence of Rab binding, REP interaction with 
RabGG transferase is maintained through Rab-inde-
pendent binding sites, providing a molecular explana-
tion for the kinetic properties of Rab prenylation in 
vitro. Analysis of the effects of thermoreversible tem-
perature-sensitive (
 
mrs6
 
ts
 
)
 
 
 
mutants on vesicular trafﬁc 
in vivo
 
 
 
showed prenylation activity is only transiently 
required to maintain normal growth, a result promising 
for therapeutic approaches to disease.
Key words: choroideremia • REP1 • CHM • vesicle 
trafﬁc • MRS6
 
Introduction
 
Choroideremia (CHM)
 
1
 
 is a form of X-linked retinal de-
generation that falls under the broad classification of he-
reditary peripheral retinal dystrophies or retinitis pigmen-
 
tosa (Heckenlively and Bird, 1988).
 
 
 
The discovery of the
function of CHM came with the observation that CHM
 
gene product (Cremers et al., 1990) is identical to that
of component A or Rab escort protein 1 (REP1) of the
Rab geranylgeranyl transferase II (RabGG transferase)
protein complex. RabGG transferase posttranslationally
modifies Rab proteins with 20 carbon geranylgeranyl iso-
prene lipids (Seabra et al., 1992a), a modification essential
for Rab function (reviewed in Seabra, 1998). The function
of Rab GTPases is to regulate the docking and fusion of
vesicle carriers mediating the transport of protein between
compartments of the exocytic and endocytic pathways
(Schimmoller et al., 1998). A second, highly related iso-
form, REP2, was subsequently discovered (Cremers et al.,
1994). The sequence between the rat, mouse, and human
homologues is highly conserved (87–91%). A yeast homo-
logue, 
 
MSI4/MRS6
 
, is an essential gene and shows 
 
z
 
50%
identity with mammalian CHM (Fujimura et al., 1994;
Jiang and Ferro-Novick, 1994).
Current evidence suggests that CHM/REP1 and REP2
function by binding newly synthesized Rab proteins for
delivery to the catalytic component B of RabGG trans-
ferase (Anant et al., 1998; Alexandrov et al., 1999) that has
closely related homologues in yeast (Jiang et al., 1993; Li
et al., 1993). Component B is a heterodimer composed of
 
a
 
- and 
 
b
 
-subunits (Seabra et al., 1992a). REP has been
demonstrated to form a 1:1 protein complex with all newly
synthesized Rab proteins examined to date (Andres et al.,
1993; Anant et al., 1998; Alexandrov et al., 1999). Resi-
dues involved in binding Rab by REP or those dictating
recognition of the Rab–REP complex with RabGG trans-
ferase are unknown. After prenylation, the CHM/REP1–
Rab complex delivers the newly prenylated protein to the
membrane for use in vesicular traffic, presumably through
receptors used by the cytosolic Rab–GDI complex (Sol-
dati et al., 1994; Ullrich et al., 1994; Luan et al., 1999).
Thus, REP proteins can associate with both the unpren-
ylated and prenylated forms of Rab, and function in the
first step of delivery of Rab to membranes (Andres et al.,
1993; Alexandrov et al., 1994; Cremers et al., 1994). REP1,
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but not REP2, is missing from lymphoblasts prepared from
CHM patients (Seabra et al., 1993), and loss of REP1
serves as a practical diagnostic test for CHM (MacDonald
et al., 1998). Only truncations leading to complete loss of
protein are correlative with disease. The underlying defect
in response to REP1 loss in CHM leading to retinal degen-
eration remains to be established. Given the essential role
of REP1 in the geranylgeranylation of Rab proteins, a
leading hypothesis is that defective prenylation of one or
more isoforms of Rab that are substrates for REP1 results
in defects in vesicular trafficking in cells comprising the
choriocapillaris and retinal pigmented epithelium (RPE),
initiating retinal degeneration.
Further insight into the function of CHM came with the
realization that it shows sequence similarity (
 
z
 
30%) to
guanine nucleotide dissociation inhibitor (GDI) involved
in the recycling of small GTPases belonging to the Rab
gene family (Fodor and Lee, 1991). GDI is largely specific
for only the prenylated form and, therefore, does not par-
ticipate in delivery of nascent Rab to the catalytic subunits
of RabGG transferase (Sasaki et al., 1990; Alexandrov et al.,
1994; Wu et al., 1998). Whereas regions of homology are
observed throughout the primary sequence, three regions
of high identity have been noted (Waldherr et al., 1993).
One of these, an NH
 
2
 
-terminal sequence conserved region
(SCR1), has a 23/46 identical match for conserved amino
acids, whereas a second region found towards the middle
of the protein (SCR3B) has a 21/42 match. Other regions,
including SCR2 and SCR3A, are less conserved. We have
demonstrated using X-ray crystallography that SCR1 and
SCR3B interact to form a Rab-binding domain at the apex
of 
 
a
 
-GDI (Schalk et al., 1996; Luan et al., 2000).
The critical role of REP in the function of Rab GTPases
involved in membrane transport throughout the endocytic
and exocytic pathways stresses the importance of under-
standing the contribution of individual amino acid resi-
dues in directing the interaction of CHM/REP1, not only
with different Rab species, but importantly, the catalytic
subunits of RabGG transferase. To gain insight into the
underlying molecular basis for these interactions, we have
turned to the yeast homologue, 
 
MRS6
 
 (Waldherr et al.,
1993; Jiang and Ferro-Novick, 1994). 
 
Saccharomyces cere-
visiae
 
 contains only a single copy of the gene and it is es-
sential for cell growth. We find that point mutations en-
coding homologous residues of 
 
a
 
-GDI involved in Rab
binding in vitro (Wu et al., 1998; Luan et al., 1999) exhibit
deficiency in Rab binding and loss of prenylation in vitro,
yet supported partial growth when present as the only
copy in a 
 
mrs6
 
D
 
 
 
null strain
 
 
 
in vivo. When combined in
double mutants, complete loss of Mrs6p function was ob-
served in the 
 
mrs6
 
D
 
 
 
null strain, yet dominant effects on
growth were observed in wild-type cells. The important
implications of these results on the general mechanism of
the REP-regulated prenylation cycle in the general biol-
ogy of the vesicular traffic and in eye dysfunction in CHM
are discussed.
 
Materials and Methods
 
Strains, Plasmids, and Media
 
Yeast strains used in this study were SEY6210a/
 
a
 
 (
 
MAT
 
a
 
/MAT
 
a
 
 ura3
leu2 his3 trp1 lys2 suc2
 
D
 
9
 
; obtained from S. Emr, Howard Hughes Medi-
cal Institute, University of California San Diego), SEY6210 
 
D
 
mrs6
 
, and
SEY6210 
 
MRS6
 
ts
 
. Yeast strains were grown in standard media containing
yeast extract, peptone, and dextrose (YPD; Sherman et al., 1979) or syn-
thetic media (SM) supplemented with essential amino acid supplements
(Sherman et al., 1979) as required for maintenance of plasmids. An 
 
mrs6::
LEU2
 
 disruption plasmid used for generating the 
 
mrs6
 
 null strain was
constructed by replacing the 1,285-bp DNA fragment encoding the amino
acids 2–570 of Mrs6p with a 1,812-bp fragment containing the 
 
HIS3
 
 gene.
An 
 
mrs6
 
D
 
 strain was constructed by transformation of a wild-type diploid
strain (SEY 6210a/
 
a
 
) with a CEN 
 
URA3
 
 plasmid containing 
 
MRS6
 
, fol-
lowed by transformation of this strain with the 
 
mrs6
 
D
 
:
 
:
 
HIS3
 
 deletion-dis-
ruption construct. After confirming by PCR that this strain contained one
intact and one disrupted copy of 
 
MRS6
 
, it was sporulated, and colonies
derived from Ura
 
1
 
 His
 
1
 
 spores were identified.
 
Random Mutagenesis of the MRS6 Gene
 
The 
 
MRS6
 
 gene was subjected to the random PCR mutagenesis using an
in vivo gap-repair method. Using an 
 
MRS6
 
-containing plasmid as a tem-
plate, a 2,123-bp PCR fragment was amplified under mutagenic PCR con-
ditions (Cadwell and Joyce, 1992). This fragment corresponds to the posi-
tions 
 
2
 
196 to 
 
1
 
1,927 of the 
 
MRS6
 
 gene, where the first nucleotide in the
open reading frame (ORF) is defined as the 
 
1
 
1 nucleotide. A 2
 
m
 
 LEU2
 
plasmid containing the wild-type 
 
MRS6
 
 gene was gapped to remove the
region corresponding to the ORF. The gapped plasmid and the PCR frag-
ment were then cotransformed into the yeast strain SEY6210a/
 
a
 
. Leu
 
2
 
transformants containing circular plasmids generated via homologous re-
combination were identified by growth on 5-fluoroorotic acid. Transfor-
mants were screened at the permissive temperature, 30
 
8
 
C, and at the non-
permissive temperature, 37
 
8
 
C, resulting in yeast strain SEY6210 
 
MRS6
 
ts
 
.
 
DNA Methods
 
Standard DNA manipulation (Maniatis et al., 1982) was used with restric-
tion endonucleases and modification enzymes from Boehringer, New En-
gland Biolabs, and Promega. Point mutations were introduced by using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene). All PCR-
amplified DNAs were sequenced to confirm that only the desired muta-
tions were present.
 
Yeast and Bacterial Methods
 
Transformation of 
 
S
 
.
 
 cerevisiae
 
 strains was done according to the lithium
acetate method (Ito et al., 1983) with single-stranded DNA used as carrier
(Schiestl and Gietz, 1989). Standard bacterial medium (Miller, 1972) was
used for 
 
E
 
.
 
 coli
 
 cultures. 
 
E
 
.
 
 coli
 
 transformations were done as described
(Hanahan, 1983).
 
Protein Expression, Purification, and
Antibody Production
 
NdeI (position 
 
1
 
1) and BamHI (position 
 
1
 
 1,818) sites, respectively, were
created in the 
 
MRS6
 
 ORF. After PCR amplification, the 1.8-kb NdeI–
BamHI fragment was cloned into the pET11d vector (Novagen) contain-
ing a 5
 
9
 
 six-histidine (6xHis) tag. The 6xHis-tagged Mrs6p was expressed
and purified from 
 
E
 
.
 
 coli
 
 extracts by native purification on Ni
 
2
 
1
 
-agarose as
described by the manufacturer (Qiagen), followed by gel filtration and
concentration. The anti-Mrs6p polyclonal antibody was raised in rabbits
and the antibody purified using affinity column containing Mrs6p accord-
ing to the manufacturer’s directions (Affi-Gel, BioRad). The YPT1 ex-
pression plasmid, pET11dYPT1, was a gift from Dr. S. Ferro-Novick
(Yale University, New Haven, CT). The Ypt1p protein was purified from
 
E
 
.
 
 coli
 
 extracts as described (Wagner et al., 1987). The anti-Ypt1p mouse
monoclonal and anti-Ypt1p rabbit polyclonal antibodies were a gift from
Dr. D. Gallwitz (MPI, Gottingen, Germany). His6-tagged Rab3A ex-
pressed from 
 
E
 
.
 
 coli 
 
and prenylated His6-tagged Rab3A expressed from
 
Spodoptera frugiperda
 
 (
 
Sf9
 
) were purified as described (Nuoffer et al.,
1995; Schalk et al., 1996).
 
Growth Analysis
 
Cells were grown overnight in selective medium. The cells were then di-
luted and sonicated to separate them into individual cells. Subsequently,
the cells were counted and diluted to 1,000, 400, 100, and 10 cells/
 
m
 
l. 5 
 
m
 
l
of each dilution was spotted onto selective plates. The plates were incu-
bated at 30
 
8
 
C and growth was assessed after 2–4 d. 
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Metabolic Labeling and Immunoprecipitation
 
Yeast cultures were radiolabeled using previously published procedures
(Horazdovsky and Emr, 1993; Horazdovsky et al., 1994). Immunoprecipi-
tations of carboxypeptidase Y (CPY) were done as described (Klionsky et al.,
1988). Immunoprecipitations of HA epitope-tagged Mrs6p proteins were
done with an mAb to the HA tag (12CA5; Amersham Pharmacia Bio-
tech). Cells were washed and resuspended (50 OD
 
600
 
 U/ml) in standard
buffer (20 mM Hepes, pH 6.2, 200 mM sorbitol, 100 mM potassium ace-
tate, 2 mM MgCl
 
2
 
, 1 mM dithiothreitol), and were then broken by vortex-
ing with glass beads on ice. The homogenates were centrifuged at 100,000 
 
g
 
for 1 h to yield membrane and cytosolic fractions. Anti-HA antibody was
added (20 
 
m
 
g/ml), incubated with rocking at 4
 
8
 
C for 2 h, and HA-tagged
antibody containing Mrs6p recovered using G–Sepharose as described by
the manufacturer (Amersham Pharmacia Biotech).
 
Subcellular Fractionation
 
Spheroplasts made from cells were labeled and processed as described
(Gaynor et al., 1994). After clearing extracts of unbroken cells, lysates
were centrifuged at 100,000 
 
g 
 
for 1 h to yield P100 particulate (membrane)
and S100 soluble (cytosolic) fractions. Proteins were precipitated with
chloroform/methanol (Wessel and Flugge, 1984), separated by SDS-
PAGE, and immunoblotted using a polyclonal rabbit antisera raised
against the Ypt1p protein.
 
Distribution of Ypt1p
 
Cells were grown to early logarithmic phase at 30
 
8
 
C in selection medium.
Then one half of the culture was maintained at the permissive tempera-
ture (30
 
8
 
C) and the other half was incubated at the restrictive temperature
(37
 
8
 
C). At each time point, 5 OD of cells was washed and resuspended in
standard buffer, and permeabilized by vortexing with 1 vol of glass beads
on ice. After removing the cell debris by low-speed centrifugation, the su-
pernatant was subjected to centrifugation at 100,000 
 
g 
 
for 1 h to separate
the membrane from the cytosolic fraction. After precipitation of the cyto-
solic proteins with chloroform/methanol (Wessel and Flugge, 1984), the
proteins from both fractions were separated by SDS-PAGE and immuno-
blotted using anti-Ypt1p antibodies. The distribution of Ypt1p was quanti-
tated using densitometry.
 
Geranylgeranylation Assay
 
Rab geranylgeranyltransferase activity was assayed by incubating 
 
E
 
.
 
 coli
 
-
produced Ypt1p with [
 
3
 
H]geranylgeranyl pyrophosphate (Seabra and
James, 1998). A 60-
 
m
 
l reaction contains 50 mM Tris/HCl, pH 7.5, 5 mM
dithiothreitol, 10 mM MgCl
 
2
 
, 0.5 
 
m
 
l
 
 
 
[
 
3
 
H]geranylgeranyl pyrophosphate (20
Ci/mmol), 10 
 
m
 
g of 6xHis-Ypt1p, and 250 
 
m
 
g of yeast crude extract. The
reaction mixture was incubated at 30
 
8
 
C. After incubation, the reaction
mixture was applied onto Whatman GF/A paper and washed twice with
ethanol. The filters were dried and radioactivity was counted in a scintilla-
tion counter.
 
Fluorescence Assay
 
An assay to measure methylanthraniloyl guanosine diphosphate (mGDP;
Molecular Probes) binding to Rab GTPases was performed as described.
In brief, recombinant His6-Rab3A from 
 
E
 
.
 
 coli
 
 and 
 
Sf9
 
 cells was loaded
with the fluorescent GDP analogue, mGDP, by incubating mGDP and
His6-Rab3A at a 100:1 molar ratio in 50 mM Tris/HCl, pH 7.2, 10 mM
EDTA, 1 mM dithiothreitol, 100 
 
m
 
M mGDP at 32
 
8
 
C for 45 min. At the
end of the incubation, the mixture was adjusted to 20 mM MgCl
 
2
 
 (to trap
mGDP in Rab) and incubated 15 min more at 32
 
8
 
C. The mixture can be
kept on ice for 1 h before use. The free mGDP was removed by using Mi-
croSpin™ G-25 columns (Amersham Pharmacia Biotech). The dissocia-
tion of mGDP from His6-Rab3A was assessed by measuring the decrease
in relative fluorescence (
 
l 
 
excitation 360 nm, 
 
l 
 
emission 440 nm) using a
Perkin-Elmer LS50B Fluorescence Spectrometer as described. The disso-
ciation was measured using 100 nM Rab3A mGDP incubated with in-
creasing concentration of Mrs6p in 300 
 
m
 
l of buffer A (25 mM Tris-HCl,
pH 7.2, 0.3 mM GDP, 0.5 mM MgCl
 
2
 
, 0.6 mM EDTA). Dissociation con-
stants (
 
K
 
d
 
) for His6-Rab3A binding to His6-Mr6p wild-type and mutants
were determined as previously described for His6-Rab3A and GDI (Wu
et al., 1998).
 
Electron Microscopy
 
Cells were grown to early logarithmic phase at 30
 
8
 
C in YPD or selection
medium. Then, each culture was divided and one half was maintained at
the permissive temperature (30
 
8
 
C), and the other half was incubated at
the restrictive temperature (37
 
8
 
C). After 3 h of incubation, the cells were
fixed with 3% glutaraldehyde and processed for EM as described (Rieder
et al., 1996).
 
Results
 
A Structural Basis to Characterize Residues in Mrs6p 
Required for Function
 
As a basis to begin to explore the crucial residues involved
in REP function in Rab prenylation, we focused on the key
features derived from the molecular and structural align-
ment of CHM/REP1 and GDI family members (Wu et al.,
1996). Such an alignment shows four sequence-conserved
regions (SCRs) located in the NH
 
2
 
-terminal and central
areas with an insert of variable length separating SCR1
and SCR2 (Wu et al., 1996; Fig. 1). Residues comprising
motifs SCR1A and 1B (Fig. 1, yellow), and SCR3B (Fig. 1,
red) are particularly diagnostic of REP/GDI-related pro-
teins, due to their striking composition of invariant di- and
tripeptides (Waldherr et al., 1993). These particular mo-
tifs, defined by the consensus sequences DVxxxGTGxx-
Exx (SCR1A), GxxVLHxDxxxYYGxY (SCR1B), and
GExxQGFxRxxAxxG (SCR3B) define members of the
REP/GDI superfamily (Waldherr et al., 1993). These mo-
tifs reveal that SCR1 and 3B form a compact region found
at the apex of the protein in domain I (Fig. 1, red and yel-
low; Schalk et al., 1996). Residues Tyr39, Glu233, Gln236,
and Arg240, which are strongly conserved residues in the
SCRs, 1B (GxxVLHxDxxxYYGxY) and 3B (GExxQG-
FxRxxAxxG), between GDI and REP family members,
and are required for 
 
a-GDI binding to Rab (Schalk et al.,
1996; Wu et al., 1998) and, when mutated, lead to loss of
function in yeast (Luan et al., 1999). In contrast, conserved
residues common to both Mrs6p and GDI that are found
in SCR2 (Fig. 1, green) and 3A (Fig. 1, purple) extend the
full-length along one face of GDI (Schalk et al., 1996) and
contribute to the organization of a lower structurally de-
fined region, referred to as domain II (Fig. 1; Schalk et al.,
1996). We have recently provided direct evidence that in
the case of GDI, domain II is involved in the interaction of
GDI with Rab recycling factors (RRF), receptors mediat-
ing Rab retrieval after vesicle targeting and fusion (Luan
et al., 1999, 2000). The conserved residues in common be-
tween GDI and Mrs6p are likely to correspond to simi-
lar structural arrangements, providing a basis to explore
Mrs6p at the molecular level.
A Model System to Study REP Function in Yeast
The currently recognized biological function common to
members of the GDI and REP families is to bind a diverse
group of Rab proteins. Because the highly conserved
SCR1 and 3B motifs fold to generate a compact region at
the apex of GDI in domain I, it was a strong candidate for
direct participation in Rab association by CHM/REP1.
The yeast S. cerevisiae contains a single REP homologue,
MRS6 (Waldherr et al., 1993; Jiang and Ferro-Novick,
1994), that is essential for cell growth. Therefore, we car-The Journal of Cell Biology, Volume 150, 2000 92
ried out a systemic screen of mutants in Mrs6p for function
in Rab binding and prenylation in vitro, and cell growth
and transport in vivo.
To map amino acid residues of Mrs6p that are important
for function, a plasmid shuffle-based complementation as-
say was developed that allowed rapid screening of site-
directed point mutants for their ability to complement an
mrs6D  null mutation (Table I). mrs6 plasmids (CEN
LEU2) containing site-directed mutations were used to
transform a mrs6D::HIS3 null strain containing a CEN
URA3  MRS6 plasmid as the sole source of wild-type
Mrs6p. Transformed strains were streaked to 5-flouro-
orotic acid (5-FOA) plates to select for loss of the URA3
MRS6 plasmid leaving the mutant mrs6 gene as the only
Figure 1. Potential location of substitutions
(yeast numbering) based on the crystal struc-
ture of bovine a-GDI. The tentative location
of each of the residues (Mrs6p residue num-
bering) mutated in this study based on their
homologous residue in a-GDI (Table I) are
indicated (Schalk et al., 1996). The insert re-
gion (blue) and the Rab-binding region con-
taining SCRs 1B (yellow) and 3B (red) are
highlighted at the top of GDI and form do-
main I. The conserved face of GDI containing
SCRs 2 (green) and 3A (purple) link domain
I with a second domain II, and are oriented to
the front of the image (Schalk et al., 1996).
Bolded residues are those that have promi-
nent phenotype in altering REP function.
Table I. Effect of Single Point Mutations in Mrs6p on Growth of the 6D Null Strain
Region Location Residue mutated Growth at 308C Yeast GDI residue Mammalian GDI residue
Wild-type 2 2 111 2 2
SCR1A a1 strand D48N 111 11 5
SCR1A a1 loop A G53A 111 16 11
SCR1A a1 loop A G55A 111 18 13
SCR1B a2 loop f1 D76N 11 39 34
SCR1B a2 loop f1 Y81V 111 44 39
2 B helix K99D 111 59 55
SCR2 f2 strand R127A 111 78 70
SCR2 b2 strand E174Y 111 125 117
SCR2 D helix T185D 111 136 128
SCR2 E helix R195A 1 146 138
SCR2 E helix K199D 11 150 142
SCR2 E loop F E208Q 111 160 152
2 F helix L226Y 111 180 172
SCR3A H loop e3 D269A   111  225  217
SCR3A H loop e3 V270R 111 226 218
SCR3A H loop e3 Y271F 111 227 219
SCR3B I helix E286S 1 241 233
SCR3B I helix Q289L 111 244 236
SCR3B I helix R293A 1 248 240
SCR3B a3 strand T301P 111 256 248
2, Dead; 1, slow; 11, slower than wild-type; 111, like wild-type.Alory and Balch Rab Escort Protein (REP)/Choroideremia (CHM) Function 93
source of Mrs6p. Growth of the resultant strains was as-
sayed after restreaking to rich medium. This method al-
lowed us to assess if any mrs6 mutants constructed were
able to supply the essential function of MRS6. As a test to
confirm the feasibility of this approach, a double mutant,
G53A-G55A, was introduced into MRS6. Based on the
crystal structure of GDI, the conserved nature of these
residues, and their buried location in the protein (Schalk
et al., 1996), we predicted that this double mutant would
affect the structural integrity of Mrs6p, as it does for GDI
(Schalk et al., 1996; Wu et al., 1998; Luan et al., 1999), and
lead to a complete loss of function through misfolding. In-
deed, the double mutant failed to yield Leu1 Ura2 strains
after streaking to 5-FOA plates, indicating noncomple-
mentation of the mrs6D null mutation and thus confirming
the validity of this assay (see below, Table II).
Generation of Single Point Mutants Partially Defective 
in Mrs6p Function
Mutation of conserved residues in SCRs 1B and 3B found
at the apex of GDI affect the ability of the a-GDI to bind
Rab3A in vitro (Schalk et al., 1996) and for function in
yeast in vivo (Luan et al., 1999). Therefore, we used
the crystallographic structure (Schalk et al., 1996) and the
aligned sequences of all GDIs and REPs comprising the
GDI superfamily as a guide to generate point mutations
changing conserved, surface-exposed amino acids of the
various SCRs that would not affect protein folding or sta-
bility, but that were likely candidate residues for interac-
tions with Rabs and RabGG transferase. The mutants ex-
amined are shown with respect to their corresponding
location in GDI (Fig. 1, residue numbers are those of
Mrs6p). Each was tested in the complementation assay.
The results of our analysis is shown in Table I. Despite
the extensive collection of point mutants tested, no single
amino acid change was found that resulted in a complete
loss of Mrs6p function. However, several point mutations,
notably R195A, E286S, and R293A (yeast Mrs6p number-
ing) affected growth as is evident by the slower growth of
these strains (Table I; Fig. 2, A and C). R195A is located
in domain II, whereas E286S and R293A are found in
SCR3B (Fig. 1). In particular, R293A (Table I) was previ-
ously shown to be important in mammalian and yeast GDI
function and is crucial for Rab binding in vitro and in vivo
(Schalk et al., 1996; Wu et al., 1998; Luan et al., 1999).
From these results, and by analogy to the effect of similar
mutants for binding of Rab in vitro by GDI (Schalk et al.,
1996; Wu et al., 1998; Luan et al., 1999, 2000), potentially
even reduced levels of Rab recognition by REP are suffi-
Table II. Effect of Double Mutants on the Growth of mrs6D 
Null and Wild-type Strains
 Growth at 308C in:
Mutants yrepD strain  wt strain Mammalian GDI residue
Wild-type 111 NE  2
G53A-G55A 2 NE  11–13
Y81V-G53A 111 NE  11–39
Y81V-293A 1 NE  39–240
R127A-R293A 2 NE  70–240
R195A-R293A 2 Dominant negative  138–240
L226Y-R293A 2 NE  172–240
D269A-R293A 1 NE  217–240
V270R-R293A 1 NE  218–240
Y271F-R293A 1 NE  219–240
E286S-R293A 2 Dominant negative  233–240
T301P-R293A 1 NE  240–248
1, Dead; 1, very slow; 111, like wild-type; NE, no effect.
Figure 2. Ability of selected single and double point mutants to
complement growth of mrs6D null strain. A, Indicated mutants
were expressed in the mrs6D null strain using the single copy
CEN plasmid as described in Materials and Methods. B, Indi-
cated mutants were expressed using the single copy CEN plas-
mid, or multicopy 2m plasmid in wild-type cells. The ability of
overexpressed Mrs6p double mutants to partially inhibit growth
is illustrated by reduced level of colonies appearing on the plate.
C, Indicated mutants were expressed in the mrs6D null strain us-
ing the single copy CEN plasmid as described in Materials and
Methods. 5,000, 2,000, 500, and 50 cells were spotted onto a plate.
The growth was assessed after a 2–4-d incubation at 308C.The Journal of Cell Biology, Volume 150, 2000 94
cient to maintain a functional Rab pool in vivo for cell sur-
vival. We suggest that the prenylation activity of wild-type
REP is likely to be in functional excess in living cells.
Double Mutants Demonstrate the Essential Role of the 
Rab-binding Platform in Mrs6p Function
Because the E286S and R293A mutants showed compara-
ble slower growth phenotypes (Table I), we chose the
R293A mutation as a starting point to construct a set of
double mutants. Additional amino acid substitutions were
made in either the same SCR containing R293 (SCR3B;
Fig. 1, red) or in different SCRs, and each of these was
tested in combination with R293A in the complementa-
tion assay (Table II). We also generated double mutants
within and between SCRs that did not include the R293
residue, to test whether multiple mutations in regions
flanking the putative Rab-binding platform would yield
defective function.
While many of the double mutants did complement
growth (Table II and not shown), five double mutant
combinations with R293A complemented the mrs6D null
strain with a similar phenotype to the single R293A mu-
tant, whereas four had additional more-lethal phenotypes
(Table II; Fig. 2 A and not shown). Like single mutants, all
double mutants (with the exception of G53A-G55A dis-
cussed above) were found to be expressed at levels similar
to wild-type Mrs6p when examined by immunoblotting
(see Fig. 4 A and not shown), suggesting that instability or
proteolysis was not responsible for loss of function of dou-
ble mutants in the mrs6D null strain. Significantly, one of
the strong double mutant combinations, E286S-R293A
(Table II; Fig. 2 A), contained residues that, when mu-
tated separately, previously have been implicated directly
in Rab-binding in vitro and in vivo by GDI (Schalk et al.,
1996; Wu et al., 1998). Thus, full disruption of the physio-
logical function of Mrs6p in vivo may require mutation of
at least two surface residues in the putative Rab-binding
region. Notably, when the E286S-R293A double mutant
was transformed into the MRS6 wild-type strain on a 2m
vector to promote overexpression, we observed significant
inhibition of growth compared with a similar level of over-
expression of the wild-type Mrs6p, which shows no effect
(Fig. 2 B; Table II). These results raise the possibility that
this Mrs6p double mutant can act as a potent competitive
inhibitor of prenylation (not observed by overexpression
of wild-type Mrs6p) by either inappropriately competing
for binding to endogenous unprenylated Rab species, or,
more likely, by binding to the catalytic components of
RabGG transferase or membrane-associated receptors in-
volved in Rab recycling.
An additional residue in domain I was found to be re-
quired for Mrs6p function in combination with R293 was
R127 (Table II). R127 is found in the insert region in
a-GDI (Fig. 1, blue). Loss of function in support of growth
of the mrs6D null strain was similar to that observed for
the E286S-R293A mutant (Table II). This region is greatly
expanded in mammalian REP (Wu et al., 1998). More-
over, a similar residue in GDI was also found to be essen-
tial for specific aspects of a-GDI function (Wu et al.,
1998). These results imply a role for the insert region adja-
cent to the Rab-binding platform in GDI/REP superfam-
ily function. In the case of REP, one possibility is that this
region may provide additional sites for interaction with
unprenylated, nascent forms of Rab to insure efficient de-
livery to RabGG transferase.
We also noted that the R195A mutant showed a slower
growth phenotype, particularly in combination with R293A
(Fig. 2 A; Tables I and II). Moreover, R195A-R293A, like
E286A-R293A, had a partial dominant suppressing effect
on growth when overexpressed in wild-type cells (Fig. 2 B,
Table II). R195 is present in domain II, a region that we
have now implicated in interaction with membrane recep-
tors (Luan et al., 2000). These results suggest an important
role for residues outside the Rab-binding region in REP
function, leading us to conclude that both the domain I and
domain II (Fig. 1) play a key role in REP activity.
Double Mutants Will Not Complement the Growth 
Defect in Temperature-sensitive mrs6ts Cells
To further define the function of the mutant Mrs6p pro-
teins that failed to complement the mrs6D null strain, we
examined if they could complement the growth defect of
yeast strains expressing a temperature-sensitive (ts) Mrs6
protein (Mrs6pts). For this purpose, MRS6 was treated to
random PCR mutagenesis and subsequently used to re-
place wild-type MRS6 by the gapped plasmid repair trans-
formation method. Ts-variants were identified by replica
plating and incubation at 308C (permissive) or 378C (non-
permissive) temperature. Five ts-variants that failed to
show colonies on agar plates at the restrictive tempera-
ture, but which grew normally at the permissive tempera-
ture (Fig. 3 A), were identified and the mutations mapped.
Figure 3. Growth of the
mrs6ts  strain. A, The indi-
cated temperature-sensitive
strains (clones 1, 13, 14, 17,
and 38) were incubated at the
permissive (308C; left) or the
restrictive (378C; right) tem-
perature. B, Growth of clone
14 at the permissive (open
squares) or restrictive (open
circles) temperatures. In the
curve shown by the closed
squares, the culture was ex-
posed to the permissive
temperature for 15 s before
reequilibration to the restric-
tive temperature (z2 min to-
tal time at the permissive
temperature).Alory and Balch Rab Escort Protein (REP)/Choroideremia (CHM) Function 95
All showed single point mutations in key structural ele-
ments (a helices and b strands) found in analogous resi-
dues in GDI (not shown). Thus, these structural elements
are likely to be destabilized by incubation at elevated tem-
perature.
A typical growth curve for one of the ts-variants (clone
14) is shown in Fig. 3 B. Growth within the first generation
was markedly reduced after shift to the restrictive temper-
ature. Given that prenylated Rabs are relatively stable
molecules, requiring at least a single generation for turn-
over, the decreased rate of growth is likely to reflect pro-
gressively reduced pools of prenylated Rab proteins avail-
able to promote membrane traffic and cell division. The
immediate onset of a reduced rate of growth suggests that
Mrs6pts may be rapidly inactivated after shift to the re-
strictive temperature. Remarkably, when cells grown at
the restrictive temperature (378C) are exposed to 308C for
less than two minutes at hourly intervals, growth was nor-
mal (Fig. 3 B). This illustrates that clone 14 phenotype is
thermoreversible in vivo. Moreover, the ability of the mu-
tant Mrs6pts to rapidly refold and burst prenylate, an un-
prenylated Rab pool illustrates that REP function is only
transiently required to support normal growth (about two
minutes per generation). This may have important impli-
cations for understanding the basis of disease and thera-
peutic approaches to CHM (see Discussion).
To assess whether single or double mutants will comple-
ment loss of Mrs6pts function at the restrictive tempera-
ture, mutant genes on CEN vectors were transformed into
the  mrs6ts strain, and transformants were selected and
maintained at 308C. Transformants were then restreaked
and shifted to 378C for three days and the growth of each
of the strains was assessed. Consistent with the above re-
sults, single mrs6 mutations suppressed the ts growth de-
fect in a comparable fashion to that observed in the mrs6D
null strain (not shown). In contrast, each of the double
mutations, such as R195A-R293A and E286S-R293A, that
did not complement the mrs6D null mutation (Table II)
showed a considerably reduced ability to complement the
mrs6ts mutation at 378C (not shown).
Single and Double Mutants Show Deficiencies in
Rab Binding In Vivo
Mutant mrs6 alleles that failed to complement the mrs6D
null mutation or the mrs6 ts phenotype could produce pro-
teins that were defective for folding and therefore unsta-
ble and degraded. Alternatively, they could be deficient in
any essential aspect of REP function, including Rab bind-
ing, interactions with the RabGG transferase catalytic sub-
units, or interaction of Rab with membrane receptors in-
volved in vesicular transport (Soldati et al., 1994; Ullrich
et al., 1994; Luan et al., 1999, 2000).
To distinguish between Rab binding and prenylation, a
vector was constructed that allowed us to tag mutant and
wild-type Mrs6p proteins with the influenza hemagglutinin
(HA) epitope at the COOH terminus (HA-Mrs6p). This
region in bovine GDI is disordered in the crystal structure
(Schalk et al., 1996). By analogy, the epitope tag would not
be expected to interfere with Mrs6p function. Consistent
with this conclusion, all HA-tagged constructs generated
behaved in an identical fashion to their equivalent un-
tagged versions in growth and in binding to Rab (not
shown), as has been observed of HA-tagged Gdi1p (Luan
et al., 1999, 2000). The double mutant genes and their cor-
responding single mutant genes cloned into the HA-vector
were used to transform the mrs6ts strain. Immunoblotting
of total cell lysates derived from these strains (incubated
at either the permissive or restrictive temperatures) with
an HA-specific antibody revealed that a single band of
z66 kD was present (Fig. 4 A and not shown).
To determine if the single or double mutants would bind
Rab, we used a coimmunoprecipitation assay to examine
their interaction in vivo with the Rab GTPase Ypt1p that
is required for ER/Golgi transport (Segev et al., 1988).
Extracts were prepared from strains grown at permis-
sive temperature (308C) and centrifuged at 100,000 g for
one hour to yield P100 particulate fractions containing
membranes and S100 cytosolic fractions. HA-Mrs6p was
immunoprecipitated from the S100 fractions under native
conditions and the immunoprecipitates were probed by
immunoblotting with specific antibody against Ypt1p.
Whereas Ypt1p was efficiently coimmunoprecipitated
with wild-type HA-Mrs6p (Fig. 4 B), it was only poorly
coimmunoprecipitated in extracts from strains expressing
each of the double mutants containing modified residues
in the Rab-binding platform (Fig. 4 B and not shown).
Moreover, significant but reduced and variable amounts of
Ypt1p, with the exception of the R195A mutant strain,
were coprecipitated by each of the corresponding Rab-
binding platform single mutants (E286S and R293A; Fig. 4
B and not shown). This result is consistent with the obser-
vation that these single mutants partially affect binding of
Figure 4. Coimmunoprecipitation of Ypt1p and Sec4p with wild-
type and mutant HA-Mrs6p proteins. A and B, Identical
amounts of cell homogenates of mrs6ts cells (grown at 308C [not
shown] or 378C) expressing HA epitope-tagged wild-type or mu-
tant Mrs6p proteins (indicated at the top of each lane) were
cleared of membranes by centrifugation at 100,000 g, and
HA-Mrs6p was immunoprecipitated from each supernatant frac-
tion (S100) under native conditions. In A, HA-Mrs6p was de-
tected using immunoblotting with an HA-specific antibody in cell
homogenates (before immunoprecipitation) to show that identi-
cal amounts of HA-Mrs6p are present in each sample. In B, anti-
bodies to Ypt1p were used to detect Ypt1p in the immunopre-
cipitates using immunoblotting. All blots were treated in an
identical fashion to allow quantitative comparison of levels of re-
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GDI to Rab3A in vitro and in vivo, yet still support cell
growth (Schalk et al., 1996; Wu et al., 1998; Luan et al.,
1999).
The Domain II Mutant Binds Rab Normally In Vivo
In contrast to the effects of mutations in the Rab-binding
platform on interaction of REP with Rab, the single point
mutation R195A in domain II, which poorly comple-
mented growth of the mrs6D null strain (Table I), showed
normal binding to Rab (Fig. 4 B). However, this binding
was markedly reduced in the double R195A-R293A mu-
tant (Fig. 4 B). These results now raise the intriguing pos-
sibility that domain II is specifically involved in recogni-
tion of the RabGG transferase catalytic complex.
Mrs6p Wild-type and Mutant Interactions with Rab
In Vitro
We recently reported a novel GDI-Rab binding assay to
measure the strength of Rab and GDI interactions based
on the property of GDI to prevent the intrinsic dissocia-
tion of GDP from Rab3A in combination with mGDP us-
ing fluorescence spectroscopy (Wu et al., 1998). The disso-
ciation of mGDP from Rab is determined by measuring
the decrease in relative fluorescence (l excitation 360 nm,
l emission 440 nm) that accompanies the normal release of
mGDP. As shown in Fig. 5, in a fashion similar to that re-
ported for GDI (Wu et al., 1998), addition of increasing
concentrations of recombinant, purified Mrs6p to prenyl-
ated Rab3A led to a decrease in the loss of intrinsic fluo-
rescence through formation of a Rab3A-Mrs6p-mGDP
ternary complex. Thus, Mrs6p functions as a GDI. Inter-
estingly, binding Mrs6p to the prenylated form of Rab3A
(Fig. 5 A) was stronger than that observed for unpren-
ylated forms (Fig. 5 B) based on the level of inhibition of
mGDP dissociation observed in the presence of increasing
Mrs6p (Kd 5 650 nM for unprenylated Rab3A; Kd 5 320 nM
for prenylated Rab). The approximate twofold relative in-
crease in binding is consistent with the observation that
REP is likely to function as a transient carrier for delivery
of Rab to membranes after prenylation. While the ability
of Mrs6p to bind and suppress nucleotide dissociation of
mammalian Rab3A confirms the evolutionary conserva-
tion of the Rab-binding domain in recognizing Rabs as di-
vergent as those found in yeast and mammals, it was not
possible to measure the Kd of interaction of REP with the
yeast Rab proteins Ypt1p or Sec4p, as they could not be
stably loaded with mGDP (our unpublished observations).
Using this assay, we also tested the effects of mutation
of selected residues on the ability of Mrs6p to interact with
Rab3A. As shown in Fig. 5 C, both the single and double
mutants defining the Rab-binding region of GDI (E286S-
R293A) completely interfered with the ability of Mrs6p to
prevent mGDP dissociation. Given that both single point
mutations partially supported growth in vivo, these results
emphasize the importance of these conserved residues in
both GDI and REP binding to Rab GTPases, and the fact
that even reduced activity of REP in vivo  can support
growth.
In contrast to the effects of mutants in the Rab-binding
region on binding to Mrs6p, R195A, a substitution in do-
main II that poorly supported growth (Table I; Fig. 2, A
and C) had no effect on Rab binding in vitro. Because the
double mutant (R195A-R293A) that had reduced Rab
binding had a dominant negative effect on growth in cells
expressing wild-type Mrs6p, these results provide an addi-
tional line of evidence that the single mutant may affect
the functional interaction of REP with RabGG trans-
ferase.
The Absence of Mrs6p Function Results in the 
Accumulation of Unprenylated Rab in the Cytosol
To determine if in the absence of Mrs6p function in the
clone 14 Mrs6pts strain grown at the restrictive tempera-
ture, Rab proteins showed altered distributions between
the cytosol or membranes in vivo, the P100 and S100 frac-
tions from the experiments described above were probed
by immunoblotting with a Rab-specific antibody (Fig. 6).
Interestingly, we found that compared with wild-type cells
in which the ratio of cytosol to membrane bound forms
was 0.6 at the permissive temperature, the ratio in ts cells
grown at the permissive temperature was 3, indicating an
accumulation of unprenylated Rab in the cytosol, even un-
der conditions that support normal growth. These results
are consistent with the observation that the prenylation by
the ts strain is defective in vitro and suggests that only 10–
20% of the normal membrane-associated pool found in
wild-type cells in sufficient to sustain growth. Interest-
ingly, when either the wild-type or ts cells were shifted to
the restrictive temperature for five hours, only a modest
shift in the respective cytosol to membrane ratios was ob-
Figure 5. Fluorescence assay
to measure Mrs6p-Rab3A in-
teractions in vitro. A and B,
Effect of Mrs6p wild-type
and mutants on the intrinsic
dissociation of mant-GDP
from Rab3A. Mrs6p was
added at the indicated final
concentration (mM). The in-
teraction of Mrs6p with
prenylated (A) and unpren-
ylated (B) Rab3A was de-
termined by measuring the
decrease in relative fluores-
cence (l excitation 360 nm, l
emission 440 nm) that accom-
panies the release of mant-
GDP from Rab3A as de-
scribed in Materials and
Methods. C, The interaction
of Mrs6p mutants with
Rab3A was determined by
mixing 100 nM Rab3A with
2.5 mM Mrs6p wild-type or
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served (Fig. 6). Moreover, the level of total Rab in both
the wild-type or ts strain remained the same (Fig. 6, inset).
These results suggest that in the case of the ts strain, fur-
ther misfolding of Mrs6pts at the higher temperature com-
pletely inactivated function and was responsible for the
markedly reduced rate of growth as shown previously (Fig.
3 B). These results illustrate that newly synthesized Rabs
that fail to be prenylated accumulate in the cytosol. Thus,
burst prenylation of Rabs by temporal stabilization of the
folding of clone 14 Mrs6pts during transient shift to the
permissive temperature (Fig. 3 B) may occur on either a
newly synthesized pool of Rab or the preexisting pool.
Effect of Single Point Substitutions on Prenylation
In Vitro
Because selected single and double mutations in domains I
and II of Mrs6p will either partially complement or fail to
complement growth of the mrs6ts or mrs6D null strains
(Tables I and II), respectively, a prediction is that they
should be deficient to some degree in prenylation of Rab
proteins in vitro. Prenylation activity in vitro is measured
by incorporation of 3H-GGPP to recombinant Rab added
to S100 fractions prepared from wild-type or mutant pro-
tein-expressing strains.
Single and double mutants that partially or fully comple-
mented growth were expressed in the mrs6D null strain
and extracts prepared for assay in the presence or absence
of recombinant Rab. K99D, T185D, Q289L, and Y271F,
among others, had no defect in prenylation relative to that
found for wild-type Mrs6p (Fig. 7 A), consistent with the
ability of these mutants to support normal growth (Table
I). In contrast, in the mrs6D null strain background, the
single mutants E286S, R293A, and T301P were completely
deficient in prenylation in vitro (Fig. 7 B). These domain I
residues were implicated in Rab binding in vitro and in
vivo (Figs. 4 B and 5 C). Therefore, efficient prenylation of
Rab requires binding of Rab to the Rab-binding platform.
Interestingly, the R195A mutant found in helix E of do-
main II, which showed a weak growth phenotype in vivo in
the mrs6D null strain (Table I), but showed normal Rab
binding (Figs. 4 B and 5 C), was completely deficient in
prenylation (Fig. 7 A). These results are consistent with
the interpretation that domain II function is necessary for
delivery of Rab to the catalytic subunits of RabGG trans-
ferase. In addition, a second residue, L226, found in the
adjacent helix (Fig. 1), while having no effect on growth as
a single point mutant (Table I) showed a striking effect on
growth as double mutant in combination with R293A. In
vitro, the L226A was defective in prenylation, suggesting
that this substitution contributes instability to helix F and,
therefore, loss of domain II function in vitro. We conclude
that at least two residues, one in helix E and a second in
helix F, contribute to the structure–function relationships
within the domain II–helical tripod, providing strong evi-
dence for its role in prenylation.
In general, the inability of Rab-binding platform and do-
main II mutants to support prenylation in vitro, yet sup-
port growth in vivo, suggests that prenylation in vitro is a
sensitive measure of potential effects of mutants on REP
function. The ability of single point mutants to support
growth must indicate that reduced activity of REP in vivo
Figure 6. Distribution of
wild-type and mutant Rab
proteins between cytosol and
membranes. Wild-type and
clone 14 mrs6ts strain were in-
cubated at the indicated tem-
perature. After 5 h, the same
OD of cells was lysed and
subjected to centrifugation at
100,000 g to generate a P100
membrane fraction (p) and
an S100 cytosol fraction (s).
The amount of Ypt1p in each
fraction was quantitated by
immunoblotting with specific
antibody. The inset illustrates that the amount of total Rab at the
5-h time point that was detected using immunoblotting was the
same in both the wild-type and ts strains at either 308C or 378C.
Figure 7. Analysis of prenylation activity of Mrs6p single and
double mutants in vitro. A, Single and double mutants that par-
tially or fully complemented growth were expressed in the mrs6D
strain and extracts prepared for assay in the presence or absence
of recombinant Ypt1p as described in Materials and Materials. B,
To assess the prenylation activity of inviable double mutants,
these were expressed in the mrs6ts strain and extracts prepared
for assay as indicated. The assay profile of clone 14 is typical for
that observed for clones 13, 17, and 38. Double mutants were as-
sayed in the clone 14 strain at 378C.The Journal of Cell Biology, Volume 150, 2000 98
is sufficient to generate a minimal, but functional, pool of
prenylated Rab proteins necessary for normal cell func-
tion. This observation could now account for why only
complete loss of CHM/REP1 gives rise to the hereditary
disease CHM.
Mobile Effector Domain Found in GDI Is Not Required 
for Prenylation by Mrs6p
We have recently shown that two highly conserved resi-
dues found in a mobile effector loop of GDI found in do-
main II are required for recycling of Rabs after the target-
ing and fusion of vesicles (Luan et al., 2000). Therefore, we
tested the potentially homologous residues in Mrs6p. As
shown in Fig. 7 A, mutations D269A, V270R, and Y271F
had no effect on prenylation in vitro, consistent with their
inability to support normal growth of the mrs6D null strain
and to have no effect on the growth phenotype of the
R293A mutant when expressed as double mutants (Tables
I and II). Thus, the mobile effector loop found in GDI re-
sponsible for Rab recycling after vesicle targeting and fu-
sion is not required for binding of REP to RabGG trans-
ferase, a result consistent with the observation that REP is
involved in the delivery, but not retrieval, of Rabs from
membranes.
Effect of Double Mutants on Prenylation Activity
In Vitro
To assess the prenylation activity of inviable double mu-
tants, these were expressed in the mrs6ts strain. For this
purpose, we first screened each of the Mrs6pts clones for
thermosensitive prenylation in vitro. As shown in Fig. 7 B,
three classes of activity were observed. The first group in-
cluded extracts prepared from wild-type cells grown at
308C that showed efficient prenylation at all temperatures
tested (23, 30, and 378C). The second group, including
clone 1 extracts, while efficiently prenylating Rab at 23
and 308C, showed markedly reduced levels of prenylation
upon incubation at 378C. In contrast, group 3, character-
ized by extracts prepared from clones 14 (Fig. 7 B) and 13,
17, and 38 (not shown), were unable to prenylate Rabs at
any temperature (23, 30, or 378C), suggesting that al-
though the folding of these variants was sufficiently stable
to support growth in vivo, they were not stable under our
current in vitro incubation conditions, a typical character-
istic of ts variants. As expected, double mutants that were
stably expressed, but deficient in growth in vivo in the
mrs6ts strain, were deficient in prenylation in vitro in a
mrs6ts (clone 14) background at both the permissive and
restrictive temperature (Fig. 7 B).
Intracellular Membrane Trafficking in mrs6 Mutants
Rab GTPases are required for numerous membrane traf-
ficking steps in the endocytic and exocytic pathways.
These involve at least 11 different Rab proteins in yeast
and  .40 proteins in mammalian cells (Martinez and
Goud, 1998). Therefore, we examined our collection of
single point mutants for secretory transport function. We
monitored Mrs6p function in the early secretory pathway
(ER/Golgi complex) and the vacuolar protein sorting/endo-
cytic (VPS) pathway by examining the processing of CPY.
In pulse-chase immunoprecipitation assays, the conversion
of the ER p1 precursor form (67 kD) to the Golgi com-
plex-modified p2 (69 kD) precursor, reflects rapid trans-
port through the ER and Golgi complex, and conversion
of p2 form to mature CPY (61 kD) reflects transport from
the Golgi complex to the vacuole. CPY biosynthesis was
assayed at 5- and 30-min chase at 308C, time points that al-
lowed us to visualize potential reduced rates of transport
through each of these CPY biosynthetic transport steps.
For the viable Mrs6p mutants, pulse-chase assays were
conducted with strains in which the mutant mrs6 alleles
were the sole source of Mrs6p. As shown in Fig. 8, the
R195A mutant and the R127A (that showed normal
growth in the mrs6D null strain; Table I) transported CPY
at a rate characteristic of that observed in wild-type cells.
Transport was rapid at 308C and nearly complete within
the 5-min chase period as indicated by the appearance of
the mature form (Fig. 8 A, m, compare a, b, and c); results
quantitated in Fig. 8 B). In contrast, two of the single mu-
tants, E286S and R293A, clearly exhibited defects in CPY
biosynthesis that reflected partial kinetic delays in trans-
port at different steps of the secretory pathway. The
R293A mutant, which showed markedly reduced prenyla-
tion of the ER to Golgi complex-specific Rab (Ypt1p) in
vitro  (Fig. 7), demonstrated a clear reduction in ER to
Golgi complex transport leading to a decrease in the kinet-
ics of processing of the P1 (ER) to the P2 (Golgi complex)
form (Fig. 8). The fact that the p2 form was subsequently
rapidly processed to the mature vacuolar form indicates
that the major kinetic delay in the presence of this mutant
is ER to Golgi complex transport. However, the E286S
mutation showed also a potent block in transport of CPY
from the p2 (Golgi form) to the vacuole as indicated by
the transient accumulation of the p2 form at the 5-min
point. Moreover, the p2 form only partially matured to the
vacuolar form by 30 min (Fig. 8, d). These results suggest
that another yeast Rab involved in vacuolar targeting may
Figure 8. Analysis of vesicle-
mediated trafficking of mrs6
single  mutants. The indi-
cated strains in mrs6D null
cells were prepared and the
cultures were labeled with
[35S]methionine/cysteine for
20 min, then chased for 5 or
30 min. CPY was immuno-
precipitated from extracts de-
rived from each culture. The
positions of p1-CPY (ER),
p2-CPY (Golgi), and mature
(m) CPY (vacuole) are indi-
cated to the left. In wild-type
cells incubated at 378C trans-
port is very rapid. Here, CPY
is largely recovered in the
mature form, even after a
5-min chase period. B, The
distribution of CPY in the p1,
p2, and m forms at the 5-min
(top) and 30-min (bottom)
time points for each mutant
were quantitated using densi-
tometry.Alory and Balch Rab Escort Protein (REP)/Choroideremia (CHM) Function 99
not be efficiently recognized by this mutant and that dif-
ferent residues in the Rab-binding region of REP are re-
quired for efficient binding of different Rab proteins. A
similar result has been observed for GDI (Schalk et al.,
1996; Wu et al., 1998; Luan et al., 1999, 2000). As vacuolar
protein transport is not required for growth of yeast, while
ER to Golgi complex transport is essential, the kinetic de-
lay of CPY transport to the Golgi complex observed in the
presence of the R293A mutant is consistent with the re-
duced rate of growth of this mutant in the mrs6D  null
strain (Table I).
These results provide direct support for the interpreta-
tion that REP interacts differentially with Rabs to modu-
late the availability of the active, prenylated form Rab for
distinct transport steps in the exocytic pathway. This is
consistent with the need for specialized REP isoforms in
mammalian cells that have cell lineage–specific defects in
function such as found in CHM.
EM Reveals the Accumulation of Numerous Vesicular 
Structures in the mrs6ts Strain Incubated at the 
Restrictive Temperature
EM was used in an effort to visualize membrane traffick-
ing intermediates that might accumulate in mrs6ts mutants.
Clone 14 was prepared for analysis by growing at the per-
missive temperature (308C), and then the culture was di-
vided and one half was transferred to 378C and incubated
for three hours while the other half remained at 308C.
Cells were then fixed and prepared for EM.
Fig. 9 shows that the mrs6ts cells grown at the permissive
temperature (Fig. 9 B) were similar in appearance to wild-
type cells (Fig. 9 A; Vida and Emr, 1995). They contained
a dense, ribosome-rich cytoplasm dominated by a large
circular vacuole. In contrast, numerous aberrant mem-
brane structures were observed in the mrs6ts strain incu-
bated at the restrictive temperature (Fig. 9 C). Not only
were numerous vesicular structures evident throughout
the cytoplasm (Fig. 9 C, arrowheads), but the vacuole was
surrounded by large electron-lucent structures giving the
vacuole a punched-in type of appearance (Fig. 9, arrows).
This phenotype is very similar to the phenotype observed
in the sec19-1 or sec19-1 (R248A-Y44V) strains in which a
temperature-sensitive mutant of yeast GDI (sec19-1) can
be rapidly inactivated by shift to the restrictive tempera-
ture. These results illustrate that striking morphological al-
terations accompany loss of general REP function. In
CHM, where the defect is due to loss of the CHM/REP1
isoform function, early morphological phenotypes will be
expected to be highly diagnostic of the specific pathway
regulated by Rab protein(s) uniquely prenylated by CHM/
REP1.
Discussion
Our genetic and biochemical analyses provide new mecha-
nistic insight into the role of REP in prenylation of Rab
GTPases. Using site-directed mutagenesis to inactivate
Mrs6p function in yeast we have now established the phys-
iological importance of residues found in domain I of REP,
a region previously implicated in Rab binding in vitro and
in vivo to GDI (Schalk et al., 1996; Wu et al., 1998) and,
the potential role of domain II in recognition of the
RabGG transferase catalytic subunits. The importance of
these findings and their implication for the dysfunction of
the CHM/REP1 in disease are discussed below.
The Rab-binding Region Plays a Physiological Role in 
REP Function In Vivo
Previous biochemical studies based on the structure of bo-
vine a-GDI demonstrated that residues present in SCRs 1
Figure 9. EM of a mrs6ts mutant strain. The clone 14 mrs6ts mu-
tant was grown overnight at 308C, the culture was divided, and
one half was incubated at 378C for 3 h (C) while the other half
was maintained at 308C (B). In C, note the numerous large vesi-
cles that accumulate (arrowheads), and the punched-in appear-
ance of vacuoles (arrows) as a consequence of inactivation of
Mrs6p. A typical wild-type cell is shown in A.The Journal of Cell Biology, Volume 150, 2000 100
and 3B fold to form a platform at the apex of GDI that
binds Rab (Schalk et al., 1996; Wu et al., 1998; Luan et al.,
2000). We have now shown that mutation of conserved
residues found in the homologous Rab-binding platform
of MRS6, while having only a partial effect on growth
when expressed as single point mutants in the mrs6D null
or mrs6ts strain, can markedly affect their ability to bind
Rab and to support prenylation in vitro. Thus, we now
conclude that the Rab-binding platform is a universal
functional feature of the REP-GDI superfamily (Fig. 10).
Moreover, the phenotype observed under conditions in
which Rab binding is clearly reduced in vivo lead us to
conclude that REP activity is normally in functional excess
over that required to maintain a minimal pool of Rab GTP-
ases required for cell growth. This was particularly evi-
dent when we allowed a temperature-sensitive variant of
Mrs6p to function only transiently by rapid shift of cells
from the restrictive to the permissive temperature before
reincubation at the restrictive temperature. Consistent
with a rapid inactivation, growth was promptly inhibited
and prenylation in vitro was completely defective at the
restrictive temperature. Because it is apparent that un-
prenylated Rabs appear to be stable during incubation of
ts cells at the restrictive temperature, transient prenylation
of this pool is sufficient to support growth, consistent with
the fact that only a small recycling pool of Rab is sufficient
to support growth in yeast strains harboring less active,
mutant forms of Gdi1p (Luan et al., 1999). The ability of
cells to grow with marginal functional levels of REP is
likely to explain why only a complete loss of CHM/REP1
function gives rise to disease.
In contrast to the marginal effects of most single mrs6
point mutations on complementation of growth of the
mrs6D null strain, selected combinations of Rab-binding
platform mutations rendered Mrs6p inactive in vivo as
these mutants could not complement growth of mrs6ts
strain at the restrictive temperature. This is consistent with
the effect of similar double mutants in Gdi1p function in
Rab recognition in vitro and Rab recycling in vivo (Wu et al.,
1998; Luan et al., 1999). Our results now provide strong
physiological evidence that this Arg residue plays a pivotal
role, along with other residues found at the apex of GDI in
the activity of the Rab-binding platform for the REP-GDI
superfamily (Figs. 1 and 10). This conclusion is consistent
Figure 10. Domain organization of REP for
Rab-binding and prenylation. The figure
highlights principle regions involved in REP
function based on the homologous residues in
GDI through sequence alignment. Residues
shaded by the pink box in upper region (Do-
main I) directs Rab interaction; residues
shaded by the light green box in the lower re-
gion (Domain II) participate in recognition of
the catalytic subunits of GG Tr II. The mobile
effector loop involved in recognition of recy-
cling factors by GDI (Luan et al., 2000), but
not REP (this study), are indicated by the
shaded purple box at the interface of domains
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with the observation that a double mutant containing the
R293A mutation and a mutation in a residue localized to
the insert region that forms a boundary on one side of the
Rab-binding platform (R127 in Mrs6p) renders both pro-
teins inactive. These results raise the possibility that the
variable insert region also contributes to superfamily func-
tion.
Function of Rabs in Membrane Traffic Is Differentially 
Sensitive to Residues in the Rab-binding
Platform Mrs6p
Our studies have now demonstrated that the function of
REP proteins in prenylation is differentially sensitive to
single point mutations. In particular, the R293A mutant
clearly affected ER to Golgi complex transport, a result
consistent with its reduced ability to prenylate the ER to
Golgi complex-specific Rab, Ypt1p. In contrast, a different
point mutation, E286S, affected in addition post-Golgi
complex trafficking to the vacuole. One explanation for
this result is that residues in the Rab-binding pocket of
Mrs6p contribute in different ways to the strength of inter-
action between REP and distinct Rab species through
multiple polar and/or hydrophobic interactions. Such an
interpretation would be consistent with in vitro binding
studies with GDI where we (Schalk et al., 1996; Wu et al.,
1998; Luan et al., 1999) and others (Shisheva et al., 1999)
have shown that various mutations in the Rab-binding
platform differentially affect Rab binding in vitro and re-
cycling in vivo.
Role of Domain II in REP Function
We now provide evidence for the role of the domain II re-
gion (Fig. 10) in REP recognition of the catalytic subunits
of RabGG transferase. Mutation of amino acid residue
R195 in helix E had no effect on Rab binding or stability
in vivo. However, it led to reduced ability of Mrs6p to
support growth of mrs6D null strain and a striking loss of
function in prenylation of Ypt1p in vitro, particularly in
combination with an R293A substitution which weakens
Rab binding. These results suggest that this region (Fig.
10) is involved in Rab prenylation. A similar result was ob-
served for the role of the adjacent helix F. We found that
L226 is crucial for maintaining the activity of CHM in Rab
prenylation in vitro.
The importance of domain II in interacting with other
proteins is consistent with our recent studies based on the
1.04-Å structure of a-GDI (Luan et al., 2000), where we
demonstrated that residues found in a mobile effector
loop (residues surrounding Tyr271 [Mrs6p numbering], as
shown in Fig. 10) were important for interaction with
downstream receptors involved in the recycling of Rab
through RRF after vesicle targeting and fusion. Thus, do-
main II provides additional function to the members of the
GDI/REP superfamily.
Interestingly, the highly conserved residues comprising
the mobile effector loop in GDI family members are not
strictly conserved in REP. Indeed, mutation of these resi-
dues (269–271 Mrs6p numbering) failed to inhibit prenyla-
tion. Because current evidence suggests that REP is in-
volved in delivery to membranes after prenylation, but not
retrieval (Wu et al., 1996), these results provide further ev-
idence that the mobile effector loop in domain II function
of GDI is restricted to a late Rab recycling step (Luan et al.,
2000). Thus, REP, like GDI, contains two distinct regions
required for function: an upper platform found at the apex
required for binding of Rab; and a second domain com-
posed of tightly packed helices that appears to play a role
in the recognition of the a/b complex of RabGG trans-
ferase (Fig. 10).
Molecular Explanation for Kinetic Models of REP 
Interaction with Rab and RabGG Transferase
Recent biochemical studies (Anant et al., 1998; Alexan-
drov et al., 1999) have suggested the following mechanistic
model for REP in promoting Rab prenylation by RabGG
transferase. In the first step, REP and unprenylated Rab
form a binary complex that involves residues in the switch
2 region of Rab (Overmeyer et al., 1998) that are sensitive
to the nucleotide bound state, but insensitive to hypervari-
able COOH terminus. In a second step, the binding of the
Rab–REP complex to RabGG transferase occurs by a
two-stage kinetic mechanism that is independent of prenyl
substrate. The first stage is fast and concentration (Rab)-
dependent, whereas the second stage is concentration-
independent and rate-limiting. Finally, after prenylation,
the REP-prenylated Rab complex rapidly dissociates and
delivers prenylated Rab to membranes.
Our evidence now suggests that in step 1, Rab binding
principally relies on residues comprising the Rab-binding
platform of domain I (Fig. 10). In the case of REP, this
may also involve the large insert motif flanking the Rab-
binding region (Fig. 10, blue). Once bound, both domain I
containing bound Rab and domain II residues contribute
to recognition of RabGG transferase. One possibility is
that this recognition is first achieved by Rab. However,
this would be inconsistent with the fact that Rab, indepen-
dent of REP, cannot bind RabGG transferase, and that
excess wild-type REP is a competitive inhibitor of Rab
prenylation. A second, favored model, is that the first
rapid and concentration-dependent stage reflects residues
in domain II that direct the docking the Rab–REP com-
plex to RabGGTase. Support for this model comes the
fact that prenylation can be readily competed, at least in
the case of the mammalian REP protein in vitro, with un-
bound REP (Anant et al., 1998; Alexandrov et al., 1999).
Moreover, while we found that overexpression of wild-
type Mrs6p did not inhibit growth reflecting the ability of a
modest pool of prenylated Rab to function efficiently, we
found the striking result that mutation of residue 195
found in domain II showed reduced growth in the mrs6D
null background or mrs6ts background, and rendered REP
defective in prenylation activity in vitro. The second
slower and concentration-independent stage we propose
to be the presentation of hypervariable COOH terminus
of Rab to the catalytic subunit of RabGG transferase.
Rapid dissociation after prenylation would be expected to
modulate the affinity of domain II for RabGG transferase,
consistent with the fact that binding of the prenyl groups
on Rab may occur at a hydrophobic pocket situated at the
interface between domain I and II (D’Adamo et al., 1998).
This model is consistent with our studies that showed a
higher affinity of REP for prenylated Rab than for unpren-The Journal of Cell Biology, Volume 150, 2000 102
ylated Rab. Further crystallographic and molecular studies
are currently in progress to address this model.
Implications for Physiological Function of the
CHM/REP Family in CHM
REP2 appears to be the major housekeeping form distrib-
uted throughout all tissues (Cremers et al., 1994). In con-
trast, REP1 is confined to a more limited spectrum of tis-
sues, such as the RPE (Seabra et al., 1992b; Andres et al.,
1993). The differential tissue distribution of this REP iso-
form combined with our observations that residues in the
Rab-binding region contribute to selective activity in Rab
recognition and recycling (Schalk et al., 1996; Wu et al.,
1998; Luan et al., 1999) indicates a specialized role in han-
dling subsets of RPE-specific Rabs. Such specialization
may contribute to maintenance of specific types of Rab-
dependent vesicle traffic in these tissues (Seabra et al.,
1995). By analogy to the effects of various mutants in
Mrs6p, our results now demonstrate that the deficiency in
CHM may be overcome by only a modest level of in-
creased expression of REP1 or through selective augmen-
tation of REP2 function to facilitate prenylation of REP1-
specific Rabs.
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